{
    "_links": {
        "self": {
            "href": "http:\/\/localhost:8080\/article\/fastercures-announces-formation-value-coverage-advisory-council?_format=hal_json"
        },
        "type": {
            "href": "http:\/\/drupal.org\/rest\/type\/node\/article"
        },
        "http:\/\/drupal.org\/rest\/relation\/node\/article\/revision_uid": [
            {
                "href": "http:\/\/localhost:8080\/user\/2?_format=hal_json"
            }
        ],
        "http:\/\/drupal.org\/rest\/relation\/node\/article\/uid": [
            {
                "href": "http:\/\/localhost:8080\/user\/2?_format=hal_json",
                "lang": "en"
            }
        ]
    },
    "nid": [
        {
            "value": 50
        }
    ],
    "uuid": [
        {
            "value": "c2d89200-1a9d-4685-8dcf-b3f68d9a148c"
        }
    ],
    "vid": [
        {
            "value": 50
        }
    ],
    "langcode": [
        {
            "value": "en",
            "lang": "en"
        }
    ],
    "type": [
        {
            "target_id": "article"
        }
    ],
    "revision_timestamp": [
        {
            "value": "2020-02-13T07:45:06+00:00",
            "format": "Y-m-d\\TH:i:sP"
        }
    ],
    "_embedded": {
        "http:\/\/drupal.org\/rest\/relation\/node\/article\/revision_uid": [
            {
                "_links": {
                    "self": {
                        "href": "http:\/\/localhost:8080\/user\/2?_format=hal_json"
                    },
                    "type": {
                        "href": "http:\/\/drupal.org\/rest\/type\/user\/user"
                    }
                },
                "uuid": [
                    {
                        "value": "20b60d4b-bf21-4da9-8d41-4af6bd4e47ba"
                    }
                ]
            }
        ],
        "http:\/\/drupal.org\/rest\/relation\/node\/article\/uid": [
            {
                "_links": {
                    "self": {
                        "href": "http:\/\/localhost:8080\/user\/2?_format=hal_json"
                    },
                    "type": {
                        "href": "http:\/\/drupal.org\/rest\/type\/user\/user"
                    }
                },
                "uuid": [
                    {
                        "value": "20b60d4b-bf21-4da9-8d41-4af6bd4e47ba"
                    }
                ],
                "lang": "en"
            }
        ]
    },
    "status": [
        {
            "value": true,
            "lang": "en"
        }
    ],
    "title": [
        {
            "value": "FasterCures announces formation of Value & Coverage Advisory Council",
            "lang": "en"
        }
    ],
    "created": [
        {
            "value": "2015-01-29T08:44:32+00:00",
            "lang": "en",
            "format": "Y-m-d\\TH:i:sP"
        }
    ],
    "changed": [
        {
            "value": "2019-04-09T21:02:16+00:00",
            "lang": "en",
            "format": "Y-m-d\\TH:i:sP"
        }
    ],
    "promote": [
        {
            "value": false,
            "lang": "en"
        }
    ],
    "sticky": [
        {
            "value": false,
            "lang": "en"
        }
    ],
    "default_langcode": [
        {
            "value": true,
            "lang": "en"
        }
    ],
    "revision_translation_affected": [
        {
            "value": true,
            "lang": "en"
        }
    ],
    "metatag": [
        {
            "value": []
        }
    ],
    "path": [
        {
            "alias": "\/article\/fastercures-announces-formation-value-coverage-advisory-council",
            "pid": 103,
            "langcode": "en",
            "lang": "en"
        }
    ],
    "value": "WASHINGTON, D.C. -- FasterCures today announced the members of its Value and Coverage Advisory Council, a diverse group of experts who will provide guidance on fostering a coverage and reimbursement environment that incentivizes biomedical innovation and ensures that patients have meaningful access to life-saving therapies.\u201cAs pressure to cut health-care costs builds, the imperative to demonstrate value has become central,\u201d said FasterCures Executive Director Margaret Anderson. \u201cEven if we are successful at getting new treatments through the R&D and approval processes, there is no guarantee that the patients who need them will be able to access them. Building a better understanding of the evidentiary standards that payers consider when making coverage decisions and setting co-pays will help advance creative solutions.\u201dRepresenting varied interests and viewpoints \u2013 including patient groups, industry and payers \u2013 these nine advisors share a common drive to infuse patient perspectives into the coverage decision-making process. They will help guide FasterCures\u2019 efforts to advance the goals of our new Value and Coverage program, which include:Educating patient-focused foundations about the evolving coverage landscape: the issues, players and programs that could affect patients\u2019 access to specific therapiesDemonstrating the value that medical research stakeholders, including patient groups, can bring to the conversation about value and coverage\nProviding a learning environment for key stakeholders in the care and cure enterprises who are trying to develop creative solutions to make sure reimbursement policies support true biomedical innovation\nThe FasterCures Value and Coverage Advisory Council members are:Joel Brill, MD, Chief Medical Officer, Predictive Health\nMary Dwight, Senior VP for Policy and CF Community Affairs, Cystic Fibrosis Foundation\nShamiram Feinglass, MD, MPH, VP Government and Regulatory Affairs, Danaher Corporation\nElizabeth Fowler, PhD, JD, VP Global Health Policy, Johnson & Johnson\nJo Carol Hiatt, MD, MBA, FACS, Chair, National Product Council, Chair, Inter-Regional New Technologies Committee, The Permanente Federation\nRichard Pops, CEO, Alkermes\nBrian Rosen, JD, Chief Policy & Advocacy Officer, Leukemia & Lymphoma Society\nReed Tuckson, MD, FACP, Founder and Managing Director, Tuckson Health Connections\nSean Tunis, MD, MSc, President & CEO, Center for Medical Technology Policy\n\u201cIf patients are organized and empowered with the data and the insight gained through exposure to the entire drug development process,\u201d comments Richard Pops, CEO of Alkermes and a member of the Biotechnology Industry Organization\u2019s board, \u201cthey will be well positioned to have a voice that can lead to appropriate payer decisions.\u201dCystic Fibrosis Foundation\u2019s Mary Dwight adds, \u201cStakeholders in the healthcare ecosystem can rally around a therapy if there is transparency in how that therapy\u2019s value was determined. We want to bridge the gap between patient groups and payers. This is a step towards that goal.\u201dTo learn more, visit FasterCures\u2019 Value and Coverage Program or contact Lisa Bo Feng, FasterCures\u2019 associate director, Value and Coverage at lfeng@fastercures.org.The nature of service on the Value and Coverage Advisory Council is advisory, voluntary and participatory. The Council has no policy-making authority. Members are selected for their expertise and membership is not related to sponsorship; participants receive no compensation. There is an expectation for active involvement and mutual benefit from service.About <i>FasterCures<\/i><br>FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. We have only one goal: to save lives by speeding up and improving the medical research system. (www.fastercures.org)\u00a0Media Contact: Gillian Parrish, gparrish@fastercures.org, Director, Communications\u00a0# # #",
    "format": "rich_text",
    "processed": "WASHINGTON, D.C. -- FasterCures today announced the members of its Value and Coverage Advisory Council, a diverse group of experts who will provide guidance on fostering a coverage and reimbursement environment that incentivizes biomedical innovation and ensures that patients have meaningful access to life-saving therapies.\u201cAs pressure to cut health-care costs builds, the imperative to demonstrate value has become central,\u201d said FasterCures Executive Director Margaret Anderson. \u201cEven if we are successful at getting new treatments through the R&amp;D and approval processes, there is no guarantee that the patients who need them will be able to access them. Building a better understanding of the evidentiary standards that payers consider when making coverage decisions and setting co-pays will help advance creative solutions.\u201dRepresenting varied interests and viewpoints \u2013 including patient groups, industry and payers \u2013 these nine advisors share a common drive to infuse patient perspectives into the coverage decision-making process. They will help guide FasterCures\u2019 efforts to advance the goals of our new Value and Coverage program, which include:Educating patient-focused foundations about the evolving coverage landscape: the issues, players and programs that could affect patients\u2019 access to specific therapiesDemonstrating the value that medical research stakeholders, including patient groups, can bring to the conversation about value and coverage\nProviding a learning environment for key stakeholders in the care and cure enterprises who are trying to develop creative solutions to make sure reimbursement policies support true biomedical innovation\nThe FasterCures Value and Coverage Advisory Council members are:Joel Brill, MD, Chief Medical Officer, Predictive Health\nMary Dwight, Senior VP for Policy and CF Community Affairs, Cystic Fibrosis Foundation\nShamiram Feinglass, MD, MPH, VP Government and Regulatory Affairs, Danaher Corporation\nElizabeth Fowler, PhD, JD, VP Global Health Policy, Johnson &amp; Johnson\nJo Carol Hiatt, MD, MBA, FACS, Chair, National Product Council, Chair, Inter-Regional New Technologies Committee, The Permanente Federation\nRichard Pops, CEO, Alkermes\nBrian Rosen, JD, Chief Policy &amp; Advocacy Officer, Leukemia &amp; Lymphoma Society\nReed Tuckson, MD, FACP, Founder and Managing Director, Tuckson Health Connections\nSean Tunis, MD, MSc, President &amp; CEO, Center for Medical Technology Policy\n\u201cIf patients are organized and empowered with the data and the insight gained through exposure to the entire drug development process,\u201d comments Richard Pops, CEO of Alkermes and a member of the Biotechnology Industry Organization\u2019s board, \u201cthey will be well positioned to have a voice that can lead to appropriate payer decisions.\u201dCystic Fibrosis Foundation\u2019s Mary Dwight adds, \u201cStakeholders in the healthcare ecosystem can rally around a therapy if there is transparency in how that therapy\u2019s value was determined. We want to bridge the gap between patient groups and payers. This is a step towards that goal.\u201dTo learn more, visit FasterCures\u2019 Value and Coverage Program or contact Lisa Bo Feng, FasterCures\u2019 associate director, Value and Coverage at lfeng@fastercures.org.The nature of service on the Value and Coverage Advisory Council is advisory, voluntary and participatory. The Council has no policy-making authority. Members are selected for their expertise and membership is not related to sponsorship; participants receive no compensation. There is an expectation for active involvement and mutual benefit from service.About <i>FasterCures<\/i><br \/>FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. We have only one goal: to save lives by speeding up and improving the medical research system. (www.fastercures.org)\u00a0Media Contact: Gillian Parrish, gparrish@fastercures.org, Director, Communications\u00a0# # #",
    "summary": null,
    "summary_processed": ""
}